These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24913137)

  • 1. Do reward-processing deficits in schizophrenia-spectrum disorders promote cannabis use? An investigation of physiological response to natural rewards and drug cues.
    Cassidy CM; Brodeur MB; Lepage M; Malla A
    J Psychiatry Neurosci; 2014 Sep; 39(5):339-47. PubMed ID: 24913137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do motivation deficits in schizophrenia-spectrum disorders promote cannabis use? An investigation of behavioural response to natural rewards and drug cues.
    Cassidy CM; Lepage M; Malla A
    Psychiatry Res; 2014 Mar; 215(3):522-7. PubMed ID: 24398065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychophysiological responses to drug-associated stimuli in chronic heavy cannabis use.
    Wölfling K; Flor H; Grüsser SM
    Eur J Neurosci; 2008 Feb; 27(4):976-83. PubMed ID: 18333968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. fMRI study of neural sensitization to hedonic stimuli in long-term, daily cannabis users.
    Filbey FM; Dunlop J; Ketcherside A; Baine J; Rhinehardt T; Kuhn B; DeWitt S; Alvi T
    Hum Brain Mapp; 2016 Oct; 37(10):3431-43. PubMed ID: 27168331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distress intolerance moderation of motivated attention to cannabis and negative stimuli after induced stress among cannabis users: an ERP study.
    Macatee RJ; Okey SA; Albanese BJ; Schmidt NB; Cougle JR
    Addict Biol; 2019 Jul; 24(4):717-729. PubMed ID: 29737034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural responses to subliminally presented cannabis and other emotionally evocative cues in cannabis-dependent individuals.
    Wetherill RR; Childress AR; Jagannathan K; Bender J; Young KA; Suh JJ; O'Brien CP; Franklin TR
    Psychopharmacology (Berl); 2014 Apr; 231(7):1397-407. PubMed ID: 24186078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis cue reactivity and craving among never, infrequent and heavy cannabis users.
    Henry EA; Kaye JT; Bryan AD; Hutchison KE; Ito TA
    Neuropsychopharmacology; 2014 Apr; 39(5):1214-21. PubMed ID: 24264815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abstinence reverses EEG-indexed attention bias between drug-related and pleasant stimuli in cocaine-addicted individuals.
    Parvaz MA; Moeller SJ; Malaker P; Sinha R; Alia-Klein N; Goldstein RZ
    J Psychiatry Neurosci; 2017 Mar; 42(2):78-86. PubMed ID: 28245173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairments in generation of early-stage transient visual evoked potentials to magno- and parvocellular-selective stimuli in schizophrenia.
    Schechter I; Butler PD; Zemon VM; Revheim N; Saperstein AM; Jalbrzikowski M; Pasternak R; Silipo G; Javitt DC
    Clin Neurophysiol; 2005 Sep; 116(9):2204-15. PubMed ID: 16055375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological evidence of early attentional bias to drug-related pictures in chronic cannabis users.
    Asmaro D; Carolan PL; Liotti M
    Addict Behav; 2014 Jan; 39(1):114-21. PubMed ID: 24126204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural and behavioral correlates of attentional bias to cannabis cues among adults with cannabis use disorders.
    Ruglass LM; Shevorykin A; Dambreville N; Melara RD
    Psychol Addict Behav; 2019 Feb; 33(1):69-80. PubMed ID: 30589308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns in adolescent cannabis use predict the onset and symptom structure of schizophrenia-spectrum disorder.
    Shahzade C; Chun J; DeLisi LE; Manschreck TC
    Schizophr Res; 2018 Jul; 197():539-543. PubMed ID: 29402581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis abuse is associated with better emotional memory in schizophrenia: a functional magnetic resonance imaging study.
    Bourque J; Mendrek A; Durand M; Lakis N; Lipp O; Stip E; Lalonde P; Grignon S; Potvin S
    Psychiatry Res; 2013 Oct; 214(1):24-32. PubMed ID: 23906663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motivated attention to cocaine and emotional cues in abstinent and current cocaine users--an ERP study.
    Dunning JP; Parvaz MA; Hajcak G; Maloney T; Alia-Klein N; Woicik PA; Telang F; Wang GJ; Volkow ND; Goldstein RZ
    Eur J Neurosci; 2011 May; 33(9):1716-23. PubMed ID: 21450043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appetitive startle modulation in the human laboratory predicts Cannabis craving in the natural environment.
    Mereish EH; Padovano HT; Wemm S; Miranda R
    Psychopharmacology (Berl); 2018 Jul; 235(7):1933-1943. PubMed ID: 29623354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual and combined effects of cannabis and tobacco on drug reward processing in non-dependent users.
    Hindocha C; Lawn W; Freeman TP; Curran HV
    Psychopharmacology (Berl); 2017 Nov; 234(21):3153-3163. PubMed ID: 28733813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontal hypoactivation and alterations in the reward-system during humor processing in patients with schizophrenia spectrum disorders.
    Berger P; Bitsch F; Nagels A; Straube B; Falkenberg I
    Schizophr Res; 2018 Dec; 202():149-157. PubMed ID: 30539766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered striatal reward processing in abstinent dependent cannabis users: Social context matters.
    Zimmermann K; Kendrick KM; Scheele D; Dau W; Banger M; Maier W; Weber B; Ma Y; Hurlemann R; Becker B
    Eur Neuropsychopharmacol; 2019 Mar; 29(3):356-364. PubMed ID: 30658938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
    Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis use and neuropsychological performance in healthy individuals and patients with schizophrenia.
    Scholes KE; Martin-Iverson MT
    Psychol Med; 2010 Oct; 40(10):1635-46. PubMed ID: 20018124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.